Top Markets
Coin of the day
CRISM Therapeutics Corporation CRISM Therapeutics Corporation

CRISM Therapeutics Corporation

CRTX
Hisse Senetlerindeki Sıralama #40951
CRISM Therapeutics Corporation is dedicated to developing innovative drug... CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology finds particular application in treating gliomas, a form of brain tumor. The company was established in 2016 and is headquartered in Road Town, British Virgin Islands.
Hisse Fiyatı
$0.1517849
Piyasa Değeri
$58.44K
Değişim (1 gün)
11.55%
Değişim (1 yıl)
6.46%
Ülke
VG
Ticaret CRISM Therapeutics Corporation (CRTX)

Kategori

B piyasa değeri ile CRTX fiyatı
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
CRTX
$0.1517849
Piyasa Değeri CRISM Therapeutics Corporation(CRTX)
Piyasa Değeri: $58.44K
August 2026 itibarıyla CRISM Therapeutics Corporation şirketinin piyasa değeri $58.44K. Bu, verilerimize göre CRISM Therapeutics Corporation şirketini dünyanın en değerli 40951st. şirketi yapar. Piyasa değeri, halka açık bir şirketin tedavüldeki hisse senetlerinin toplam piyasa değeri olup, bir şirketin değerini ölçmek için yaygın olarak kullanılır.
CRISM Therapeutics Corporation piyasa değeri geçmişi (2003 - 2026)
En Popüler 5 stocks ile karşılaştırıldığında CRTX
CRTX’in Fiyatı B Varlığı B’nin Piyasa Değeri Sonuçlar
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$13,982,752 $58.44K
$5.383T +9,212,215,330.91%
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$11,575,544 $58.44K
$4.457T +7,626,281,624.31%
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$10,792,127 $58.44K
$4.155T +7,110,145,359.75%
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$9,515,119 $58.44K
$3.663T +6,268,817,911.09%
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$7,509,685 $58.44K
$2.891T +4,947,583,787.20%